Sinn, B. V., Weber, K. E., Schmitt, W. D., Fasching, P. A., Symmans, W. F., Blohmer, J., . . . Loibl, S. (2019). Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: Association with response and survival after neoadjuvant chemotherapy. Friedrich-Alexander-Universität Erlangen-Nürnberg. https://doi.org/10.1186/s13058-019-1231-z
Chicago-Zitierstil (17. Ausg.)Sinn, Bruno Valentin, et al. Human Leucocyte Antigen Class I in Hormone Receptor-positive, HER2-negative Breast Cancer: Association with Response and Survival After Neoadjuvant Chemotherapy. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2019. https://doi.org/10.1186/s13058-019-1231-z.
MLA-Zitierstil (9. Ausg.)Sinn, Bruno Valentin, et al. Human Leucocyte Antigen Class I in Hormone Receptor-positive, HER2-negative Breast Cancer: Association with Response and Survival After Neoadjuvant Chemotherapy. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2019. https://doi.org/10.1186/s13058-019-1231-z.